President Donald Trump’s early action on health care reversed some of his predecessor’s policies, but former President Joe ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Illinois Senator Dick Durbin called for transparency about prescription drug costs in advertisements on Thursday. He reintroduced the Drug Price Transparency For Consumers Act which would cause drug ...

Trump's executive order does not change portions of Biden's Inflation Reduction Act that created a $2,000 out-of-pocket cap on prescription drugs, placed a $35 cap on Insulin, and allowed HHS to ...

President Trump's executive order reverses Biden's order on prescription drugs, potentially increasing costs for Medicare and Medicaid enrollees.

One of President Trump's early executive orders got rid of some of the protections that reduce the cost of prescription drugs. So, what measures are still in place?

A bill that aims to increase pharmacy benefit managers’ transparency by requiring them to report data to the agency that ...

The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department ...

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...

Attorney General Gentner Drummond sued CVS Caremark Tuesday in an Oklahoma administrative court alleging that the company is ...

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.

President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.